- Home
- PETZ vs AIMD Comparison
PETZ vs AIMD Comparison
Compare PETZ & AIMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PETZ | AIMD |
|---|---|---|
| Founded | 2002 | 1984 |
| Country | China | United States |
| Employees | N/A | 41 |
| Industry | Steel/Iron Ore | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.1M | 11.5M |
| IPO Year | 2017 | N/A |
Fundamental Metrics
Financial Performance| Metric | PETZ | AIMD |
|---|---|---|
| Price | $1.59 | $1.49 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 28.9K | ★ 42.5K |
| Earning Date | 04-20-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $6.89 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.81 | $1.26 |
| 52 Week High | $1.83 | $4.44 |
Technical Indicators
Market Signals| Indicator | PETZ | AIMD |
|---|---|---|
| Relative Strength Index (RSI) | 59.55 | 46.77 |
| Support Level | $0.99 | $1.35 |
| Resistance Level | $1.37 | $1.75 |
| Average True Range (ATR) | 0.14 | 0.14 |
| MACD | 0.02 | 0.01 |
| Stochastic Oscillator | 41.67 | 57.60 |
Price Performance
Historical ComparisonAbout PETZ TDH Holdings Inc.
TDH Holdings Inc currently focus on commercial real estate management. The company has determined that it has only one operating segment which is commercial real estate leasing operations. The company has presence in China and United States of which majority of revenue comes from China.
About AIMD Ainos Inc.
Ainos Inc is a dual-platform company advancing artificial intelligence based smelltech technologies and immune therapeutics. Its primary strategic focus is the commercialization of its proprietary scent digitization platform, AI Nose, while the company also continue to develop therapeutic assets based on its low-dose oral interferon program, VELDONA. Its core technology platform, AI Nose, is an AI-based electronic olfaction system that integrates gas sensor arrays with proprietary artificial intelligence models, which it refers to as a smell language model (SLM), to digitize scent and volatile organic compound (VOC) signals into Smell ID, a machine-readable data format.